[ad_1]
Pfizer is scheduled to request emergency approval from the FDA for a COVID-19 vaccine in November.
The pharmaceutical giant has been working on a vaccine with German company BioNTech, and the companies say they have received positive results to date from trials.
If such a drug is successful, the two companies hope to produce 100 million doses by the end of 2020 and 1.3 billion next year.
Pfizer boss Albert Bourla has said he wants to provide “more clarity” around development time frames, stating that they are testing the vaccine on 38,000 people worldwide, the Financial Times reports.
In an open letter published Friday, he said Pfizer should know by the end of the month if the vaccine is effective.
He added that he would publish full details of the results, whether positive or negative.
However, he cautioned that the date could be earlier or later depending on “changes in infection rates” among those participating in the trials.
He said: “To ensure public confidence and clear up a lot of confusion, I think it is essential that the public understand our estimated timelines.”
Sign up for the Dublin Live coronavirus newsletter by simply entering your email address in this article here.
The FREE email will arrive in your inbox every morning around 9:30 am and will bring you the latest news you need to know about the coronavirus in Ireland.
Whether it’s the latest restrictions, grocery store opening hours, schools and workplaces or anything else, this newsletter will cover it all.
You can unsubscribe from this service at any time. And rest assured that your data will not be shared with any other party.
The positive news comes amid troubling times in Ireland, where another 1,000 cases were diagnosed on Friday.
The National Public Health Emergency Team has again recommended that Ireland move to a Level Five lockdown, this time for a period of six weeks.
The Covid-19 Cabinet Subcommittee will meet today to discuss such measures, with a decision expected Saturday night or possibly Sunday.
[ad_2]